Tenet Healthcare Corp (THC) shareholders
THCNYSEServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 13/3037% below fair value
$286.03−0.83 (-0.29%)
Close on Nov 13, 2026Market cap $22.76BP/E 8.3Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
100.0%
81M of 80M shares
Institutional holders
679
98 new, 102 sold out
Net institutional buying
-1M
In Q2 2026
Insider trades, 12 months
0 buys · 34 sales
Net sold $63.17M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 8,083,830 | 10.00% | 13G (passive) amendment | Aug 31, 2026 |
| T. Rowe Price Associates, Inc. | 7,954,926 | 9.20% | 13G (passive) amendment | Jun 30, 2026 |
| Vanguard Capital Management | 4,582,013 | 5.26% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of THC | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 8,743,005 | 10.99% | $1.64B | +38,361 | 0.02% |
| Price T Rowe Associates Inc /Md/ | 7,957,449 | 10.00% | $1.49B | +438,707 | 0.15% |
| Boston Partners | 4,433,360 | 5.57% | $829.06M | +598,399 | 0.74% |
| Vanguard Portfolio Management LLC | 4,238,108 | 5.33% | $792.87M | −78,779 | 0.04% |
| FMR LLC | 3,994,545 | 5.02% | $747.30M | −3,782,034 | 0.03% |
| Vanguard Capital Management LLC | 3,894,189 | 4.89% | $728.52M | −17,219 | 0.02% |
| State Street Corp | 2,751,290 | 3.46% | $514.71M | +35,365 | 0.02% |
| Glenview Capital Management, LLC | 2,235,666 | 2.81% | $418.25M | +710,812 | 7.62% |
| Geode Capital Management, LLC | 1,884,982 | 2.37% | $352.72M | −45,465 | 0.02% |
| Citadel Advisors LLC | 1,765,596 | 2.22% | $330.31M | +1,346,800 | 0.04% |
| Arrowstreet Capital, Limited Partnership | 1,708,453 | 2.15% | $319.62M | +1,036,753 | 0.14% |
| Ameriprise Financial Inc | 1,664,068 | 2.09% | $311.46M | +171,948 | 0.06% |
| Dimensional Fund Advisors LP | 1,450,408 | 1.82% | $271.35M | +249,526 | 0.05% |
| Invesco Ltd. | 1,416,948 | 1.78% | $265.08M | −370,068 | 0.02% |
| Victory Capital Management Inc | 1,237,915 | 1.56% | $231.59M | +469,857 | 0.13% |
| Norges Bank | 1,214,240 | 1.53% | $227.16M | New | 0.02% |
| Aqr Capital Management LLC | 1,067,556 | 1.34% | $198.27M | −375,032 | 0.07% |
| Alliancebernstein L.P. | 910,270 | 1.14% | $171.78M | +211,113 | 0.06% |
| Manning & Napier Advisors LLC | 901,645 | 1.13% | $168.76M | New | 2.16% |
| Bank Of America Corp /De/ | 854,858 | 1.07% | $159.93M | +83,033 | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 679 | 81M | 100.0% | 98 / 235 | 262 / 102 | 13M | 15M |
| Q1 2026 | 695 | 82M | 100.0% | 102 / 234 | 273 / 103 | 16M | 10M |
| Q4 2025 | 705 | 85M | 100.0% | 111 / 257 | 253 / 70 | 10M | 9M |
| Q3 2025 | 678 | 84M | 100.0% | 128 / 210 | 258 / 64 | 8M | 11M |
| Q2 2025 | 624 | 87M | 100.0% | 123 / 192 | 238 / 63 | 8M | 11M |
| Q1 2025 | 567 | 90M | 100.0% | 91 / 212 | 193 / 92 | 15M | 15M |
| Q4 2024 | 577 | 91M | 100.0% | 88 / 202 | 225 / 101 | 13M | 11M |
| Q3 2024 | 603 | 89M | 100.0% | 126 / 213 | 199 / 49 | 19M | 13M |
| Q2 2024 | 529 | 93M | 100.0% | 115 / 170 | 187 / 37 | 10M | 16M |
| Q1 2024 | 458 | 99M | 100.0% | 80 / 144 | 166 / 42 | 14M | 10M |
| Q4 2023 | 424 | 97M | 100.0% | 74 / 140 | 161 / 53 | 13M | 12M |
| Q3 2023 | 408 | 96M | 100.0% | 46 / 140 | 168 / 52 | 12M | 12M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
612 funds held THC in Q2 2026, 47% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of THC | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF | 2,947,772 | 3.70% | $551.47M | 0.44% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 2,734,962 | 3.44% | $511.66M | 0.02% | Jun 30, 2026 |
| T. Rowe Price Value Fund, Inc. | 2,092,106 | 2.63% | $391.39M | 1.15% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 1,975,296 | 2.48% | $369.54M | 0.20% | Jun 30, 2026 |
| Disciplined Value Mid Cap Fund | 1,528,689 | 1.92% | $285.99M | 1.23% | Jun 30, 2026 |
| Vanguard Small-Cap Value Index Fund | 1,251,377 | 1.57% | $234.11M | 0.35% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 987,687 | 1.24% | $184.78M | 0.19% | Jun 30, 2026 |
| VictoryShares Free Cash Flow ETF | 983,317 | 1.24% | $183.96M | 2.37% | Jun 30, 2026 |
| T. Rowe Price Health Sciences Fund, Inc. | 598,302 | 0.75% | $111.93M | 0.94% | Jun 30, 2026 |
| Disciplined Value Fund | 564,543 | 0.71% | $105.61M | 0.54% | Jun 30, 2026 |
| Invesco Main Street Fund | 519,819 | 0.65% | $132.44M | 1.15% | Jul 31, 2026 |
| iShares S&P Mid-Cap 400 Growth ETF | 515,290 | 0.65% | $96.40M | 0.85% | Jun 30, 2026 |
| Growth Fund of America | 472,101 | 0.59% | $82.77M | 0.02% | May 31, 2026 |
| Fidelity Extended Market Index Fund | 452,871 | 0.57% | $79.40M | 0.19% | May 31, 2026 |
| Fidelity Low-Priced Stock Fund | 439,250 | 0.55% | $111.91M | 0.45% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Saumya Sutaria | CEO, Director | 433,564 | 0.54% | Aug 26, 2026 |
| Lisa Y. Foo | EVP, Chief Operating Officer | 8,053 | 0.01% | Sep 1, 2026 |
| Paola M. Arbour | EVP, Chief Information Officer | 18,413 | 0.02% | Jul 28, 2026 |
| John Michael Grooms | Principal Accounting Officer | – | – | May 8, 2026 |
| Thomas W. Arnst | EVP, Chief Admin. Officer & GC | 12 | 0.00% | Mar 10, 2026 |
| Michael T. Maloney | EVP, Corporate Development | 101,990 | 0.13% | Mar 9, 2026 |
| R. Scott Ramsey | Principal Accounting Officer | 1,398 | 0.00% | Mar 3, 2026 |
| Sun Park | EVP & Chief Financial Officer | 23,049 | 0.03% | Mar 3, 2026 |
| Roy Blunt | Director | 3,589 | 0.00% | Nov 13, 2026 |
| J. Robert Kerrey | Director | 16,796 | 0.02% | Sep 16, 2026 |
| Richard J. Mark | Director | 25,121 | 0.03% | Sep 14, 2026 |
| Nadja West | Director | 23,653 | 0.03% | Sep 3, 2026 |
| Cecil D. Haney | Director | 12,403 | 0.02% | Aug 31, 2026 |
| Tammy Romo | Director | 28,284 | 0.04% | Aug 10, 2026 |
| Christopher S. Lynch | Director | 9,568 | 0.01% | Jul 28, 2026 |
| James L. Bierman | Director | 31,604 | 0.04% | Jul 28, 2026 |
| Vineeta Agarwala | Director | 4,446 | 0.01% | May 28, 2026 |
| Richard W. Fisher | Director | 10,125 | 0.01% | May 28, 2026 |
| Meghan Fitzgerald | Director | 17,087 | 0.02% | May 28, 2026 |
| Stephen H. Rusckowski | Director | 5,233 | 0.01% | May 27, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Roy Blunt Director | Nov 11, 2026 | Sale | −1,000 | $293.00 | $293.00K | 3,589 |
| J. Robert Kerrey Director | Sep 14, 2026 | Sale | −4,025 | $264.10 | $1.06M | 7,296 |
| J. Robert Kerrey Director | Sep 14, 2026 | Sale | −5,483 | $263.04 | $1.44M | 11,321 |
| J. Robert Kerrey Director | Sep 14, 2026 | Sale | −2,502 | $264.62 | $662.08K | 4,794 |
| Richard J. Mark Director | Sep 10, 2026 | Sale | −10,000 | $263.42 | $2.63M | 25,121 |
| Nadja West Director | Sep 2, 2026 | Sale | −1,152 | $258.80 | $298.14K | 23,653 |
| Lisa Y. Foo EVP, Chief Operating Officer | Aug 31, 2026 | Sale | −24,000 | $266.32 | $6.39M | 8,053 |
| Cecil D. Haney Director | Aug 28, 2026 | Gift | −150 | – | – | 12,403 |
| Saumya Sutaria CEO, Director | Aug 25, 2026 | Sale | −7,899 | $275.26 | $2.17M | 433,564 |
| Saumya Sutaria CEO, Director | Aug 25, 2026 | Sale | −17,220 | $273.34 | $4.71M | 466,344 |
| Saumya Sutaria CEO, Director | Aug 25, 2026 | Sale | −24,881 | $274.10 | $6.82M | 441,463 |
| Saumya Sutaria CEO, Director | Aug 24, 2026 | Sale | −36,656 | $278.90 | $10.22M | 483,564 |
| Saumya Sutaria CEO, Director | Aug 24, 2026 | Sale | −13,344 | $278.17 | $3.71M | 520,220 |
| Cecil D. Haney Director | Aug 24, 2026 | Sale | −1,300 | $278.03 | $361.44K | 12,553 |
| Tammy Romo Director | Aug 7, 2026 | Sale | −2,500 | $260.83 | $652.08K | 28,284 |
| Tammy Romo Director | Aug 6, 2026 | Sale | −4,922 | $264.15 | $1.30M | 30,784 |
| Roy Blunt Director | Aug 5, 2026 | Sale | −600 | $262.68 | $157.61K | 4,589 |
| Lisa Y. Foo EVP, Chief Operating Officer | Jul 29, 2026 | Sale | −10,000 | $258.03 | $2.58M | 32,053 |
| Paola M. Arbour EVP, Chief Information Officer | Jul 27, 2026 | Sale | −10,878 | $243.90 | $2.65M | 18,413 |
| Christopher S. Lynch Director | Jul 27, 2026 | Sale | −3,837 | $243.44 | $934.08K | 9,568 |
| James L. Bierman Director | Jul 27, 2026 | Sale | −5,000 | $244.96 | $1.22M | 31,604 |
| J. Robert Kerrey Director | May 28, 2026 | Sale | −713 | $175.13 | $124.87K | 18,070 |
| J. Robert Kerrey Director | May 28, 2026 | Sale | −905 | $176.89 | $160.09K | 17,165 |
| J. Robert Kerrey Director | May 28, 2026 | Sale | −1,690 | $173.97 | $294.01K | 18,783 |
| J. Robert Kerrey Director | May 28, 2026 | Sale | −1,969 | $173.12 | $340.87K | 20,473 |
| J. Robert Kerrey Director | May 28, 2026 | Sale | −361 | $177.52 | $64.08K | 16,804 |
| Nadja West Director | May 27, 2026 | Sale | −3,000 | $177.35 | $532.05K | 24,805 |
| Roy Blunt Director | May 22, 2026 | Returned to company | −493 | $173.78 | $85.67K | 5,189 |
| Roy Blunt Director | May 22, 2026 | Option exercise | +1,333 | – | – | 5,682 |
| Tammy Romo Director | May 22, 2026 | Option exercise | +1,333 | – | – | 36,199 |
| Tammy Romo Director | May 22, 2026 | Returned to company | −493 | $173.78 | $85.67K | 35,706 |
| Richard W. Fisher Director | May 22, 2026 | Option exercise | +1,333 | – | – | 10,125 |
| Richard W. Fisher Director | May 22, 2026 | Returned to company | −493 | $173.78 | $85.67K | 9,632 |
| Cecil D. Haney Director | May 22, 2026 | Returned to company | −493 | $173.78 | $85.67K | 13,853 |
| Cecil D. Haney Director | May 22, 2026 | Option exercise | +1,333 | – | – | 14,346 |
| Meghan Fitzgerald Director | May 22, 2026 | Returned to company | −493 | $173.78 | $85.67K | 17,087 |
| Meghan Fitzgerald Director | May 22, 2026 | Option exercise | +1,333 | – | – | 17,580 |
| J. Robert Kerrey Director | May 22, 2026 | Returned to company | −607 | $173.78 | $105.48K | 22,442 |
| J. Robert Kerrey Director | May 22, 2026 | Option exercise | +1,643 | – | – | 23,049 |
| Richard J. Mark Director | May 22, 2026 | Returned to company | −493 | $173.78 | $85.67K | 35,121 |
| Richard J. Mark Director | May 22, 2026 | Option exercise | +1,333 | – | – | 35,614 |
| Vineeta Agarwala Director | May 22, 2026 | Option exercise | +1,333 | – | – | 4,446 |
| Nadja West Director | May 22, 2026 | Returned to company | −493 | $173.78 | $85.67K | 27,805 |
| Nadja West Director | May 22, 2026 | Option exercise | +1,333 | – | – | 28,298 |
| James L. Bierman Director | May 22, 2026 | Option exercise | +1,333 | – | – | 36,604 |
| Christopher S. Lynch Director | May 22, 2026 | Option exercise | +1,333 | – | – | 13,405 |
| Paola M. Arbour EVP, Chief Information Officer | Mar 11, 2026 | Sale | −6,500 | $238.43 | $1.55M | 29,291 |
| Thomas W. Arnst EVP, Chief Admin. Officer & GC | Mar 9, 2026 | Sale | −3,286 | $239.46 | $786.87K | 12 |
| Thomas W. Arnst EVP, Chief Admin. Officer & GC | Mar 9, 2026 | Sale | −4,714 | $238.42 | $1.12M | 3,298 |
| R. Scott Ramsey Principal Accounting Officer | Mar 2, 2026 | Sale | −4,494 | $233.21 | $1.05M | 1,398 |
| R. Scott Ramsey Principal Accounting Officer | Mar 2, 2026 | Sale | −2,125 | $230.98 | $490.83K | 5,892 |
| R. Scott Ramsey Principal Accounting Officer | Mar 2, 2026 | Sale | −1,398 | $233.69 | $326.70K | 0 |
| Thomas W. Arnst EVP, Chief Admin. Officer & GC | Mar 2, 2026 | Sale | −24,000 | $234.04 | $5.62M | 8,012 |
| Saumya Sutaria CEO, Director | Feb 27, 2026 | Tax withholding | −29,919 | $239.39 | $7.16M | 658,523 |
| Saumya Sutaria CEO, Director | Feb 27, 2026 | Option exercise | +22,417 | – | – | 661,340 |
| Saumya Sutaria CEO, Director | Feb 27, 2026 | Tax withholding | −124,959 | $239.39 | $29.91M | 533,564 |
| Saumya Sutaria CEO, Director | Feb 27, 2026 | Option exercise | +36,384 | – | – | 697,724 |
| Saumya Sutaria CEO, Director | Feb 27, 2026 | Tax withholding | −9,282 | $237.58 | $2.21M | 688,442 |
| Paola M. Arbour EVP, Chief Information Officer | Feb 27, 2026 | Tax withholding | −6,810 | $239.39 | $1.63M | 35,791 |
| Paola M. Arbour EVP, Chief Information Officer | Feb 27, 2026 | Option exercise | +2,799 | – | – | 44,938 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of float
2.25%
2M shares short
Days to cover
2.2
At 1M shares a day
Change since last report
-3.3%
From 2M shares
Short volume, 20 days
48.6%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Tenet Healthcare's stock actually held short. Settlement fails (shares not delivered on time) peaked at 3,244 shares on Sep 16, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| J. Robert Kerrey Director | Sep 14, 2026 | 12,010 | $3.21M | Sep 14, 2026 | Restricted Stock Vesting |
| Richard J. Mark Director | Sep 10, 2026 | 10,000 | $2.63M | Sep 10, 2026 | Restricted Stock Vesting |
| Nadja West Director | Sep 2, 2026 | 1,152 | $298.14K | Sep 2, 2026 | Restricted Stock Vesting |
| Lisa Y. Foo Officer | Aug 31, 2026 | 24,000 | $6.39M | Aug 31, 2026 | Restricted Stock Vesting |
| Saumya Sutaria Officer, Director | Aug 25, 2026 | 50,000 | $13.70M | Aug 25, 2026 | Restricted Stock Vesting |
| Saumya Sutaria Officer, Director | Aug 24, 2026 | 50,000 | $13.94M | Aug 24, 2026 | Restricted Stock Vesting |
| Cecil D. Haney Director | Aug 24, 2026 | 1,300 | $361.44K | Aug 24, 2026 | Restricted Stock Vesting |
| Tammy Romo Director | Aug 7, 2026 | 2,500 | $652.06K | Aug 7, 2026 | Restricted Stock Vesting |
| Tammy Romo Director | Aug 6, 2026 | 4,922 | $1.30M | Aug 6, 2026 | Restricted Stock Vesting |
| Roy Blunt Director | Aug 5, 2026 | 600 | $157.61K | Aug 5, 2026 | Restricted Stock Vesting |
| Lisa Y. Foo Officer | Jul 29, 2026 | 10,000 | $2.58M | Jul 29, 2026 | Restricted Stock Vesting |
| James L. Bierman Director | Jul 27, 2026 | 5,000 | $1.22M | Jul 27, 2026 | Restricted Stock Vesting |
| Paola M. Arbour Officer | Jul 27, 2026 | 10,878 | $2.65M | Jul 27, 2026 | Restricted Stock Vesting |
| J. Robert Kerrey Director | May 28, 2026 | 5,638 | $983.92K | May 28, 2026 | Restricted Stock Vesting |
| Nadja West Director | May 27, 2026 | 3,000 | $532.05K | May 27, 2026 | Restricted Stock Vesting |
See a number that looks wrong?